DBV Technologies (DBVT) Stock: Buy, Sell, or Hold?
DBVT - DBV Technologies S.A.
$9.64
0.02 (0.21%)
▲
5d:
+5.82%
30d:
-20.79%
90d:
-29.27%
HOLD
LOW Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Oct 27, 2026
4d
Get Alerted When DBVT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: DBVT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: DBVT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: DBVT is currently trading at $9.64, which is considered slightly low relative to its 30-day fair value range of $9.47 to $12.01.
Technical Outlook: Technically, DBVT is in a strong downtrend. The price is approaching resistance at $9.92. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: DBVT scores 96/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $38.70 (+302.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, DBVT is in a strong downtrend. The price is approaching resistance at $9.92. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: DBVT scores 96/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $38.70 (+302.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$9.47 -
$12.01
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (96/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 302.2% below Wall St target ($38.70)
- CAUTION: Bottoming setup, but lagging the sector by 14% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$9.47 -
$12.01
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$8.63
Resistance Level
$9.92
Current Trend
Strong Downtrend
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-22.17
Wall Street Target
$38.70
(+302.2%)
Revenue Growth (YoY)
-53.3%
Share & Embed Analysis
Last updated: October 22, 2026 10:46 AM ET
Data refreshes hourly during market hours. Next update: 11:46 AM
Data refreshes hourly during market hours. Next update: 11:46 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DBVT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
STRONG BUY
25 analysts |
$84 | 69 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
16 analysts |
$106 | 54 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 50 HOLD |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
15 analysts |
$52 | 62 BUY |